Health Digest on MSN11 个月
The Rexulti Commercial Explained: Drug Uses, Side Effects, And More
The average cost of Rexulti with commercial insurance is almost $26, but the savings card can provide the medication for free ...
pharmaphorum2 天
FDA clears Rexulti as first drug for Alzheimer’s agitation
Lundbeck and Otsuka’s Rexulti has become the first drug to be approved by the FDA to treat agitation associated with Alzheimer’s disease, a common symptom of the neurodegenerative disorder.
pharmaphorum1 年
Rexulti backed for Alzheimer’s agitation by FDA adcomm
Analysts have suggested that approval for AAD could swell sales of Rexulti by $500 million to $1 billion, a big step up for a drug which currently makes around $1.4 billion in annual sales.
Drug Store News5 天
FDA approves Alembic’s generic Rexulti
Alembic has received permission from the Food and Drug Administration for brexpiprazole tablets, which is the generic of Otsuka’s Rexulti. Brexpiprazole is an atypical antipsychotic used as an ...
Reuters26 天
Axsome to seek approval for Alzheimer's-related agitation drug despite mixed data
Dec 30 (Reuters) - Axsome Therapeutics (AXSM.O), opens new tab said on Monday it would seek marketing approval next year for its oral drug to treat ... and aggression. Rexulti contains the FDA's ...